No Insurance Required!
Click to Sign Up Today

Seeking volunteers for a Hep C study-- Study treatment and care provided at no cost to eligible participants.

A Study Evaluating an Investigational Medication for Chronic Hepatitis C

RESEARCH STUDY

A Study Evaluating an Investigational Medication for Chronic Hepatitis C

Individuals ages 18 to 85 who have been diagnosed with chronic Hepatitis C and have never received Hepatitis C treatment may be eligible to participate in a Phase 3 clinical trial. This study is evaluating the safety and effectiveness of a new oral, once-daily investigational treatment.

Participants Receive

Study-related medical exams

The investigational oral treatment or approved medication at no cost

Compensation for time and travel may be available

Participants Receive

Study-related medical exams

The investigational oral treatment or approved medication at no cost

Compensation for time and travel may be available

You May Qualify If

You are between 18 and 85 years old

You have chronic Hepatitis C

You are willing to follow study procedures and attend regular visits

To see if you are eligible, please complete the form to get in touch with the study team.

Your privacy is important to us. By completing the following pre-screener you agree to our Privacy Policy and Terms of Use, and agree that we may retain the personal information you provide and share it with personnel involved in the study, or otherwise as described in the Privacy Policy, and we or our affiliates may contact you by phone using automated technology or pre-recorded voicemail or other means including but not limited to text messages (standard messaging rates may apply) regarding research studies.

About Hepatitis C

Hepatitis C is a liver infection caused by the Hepatitis C virus (HCV). Many people may not experience symptoms for years, but over time it can lead to serious liver damage including cirrhosis or liver cancer. This study is part of ongoing efforts to find easier, more accessible ways to treat Hep C—especially for those who haven’t yet started treatment.

About Elixia and Our Research Studies

Elixia is committed to advancing medical research by conducting clinical studies that contribute to the development of innovative options. Through these studies, researchers aim to explore new possibilities for individuals living with Hepatitis C, helping to shape the future of mental health care.

Join the Study and Help Others Living with Hepatitis C

This clinical trial is designed for individuals living with chronic Hep C – without liver cirrhosis or with compensated cirrhosis, including those co-infected with HIV.

All qualified participants will receive either an approved and marketed medication for 12 weeks or the trial medication for 8 or 12 weeks, depending on liver status. All study-related care is provided at no cost, and compensation for time and travel may be available.

Research Studies are required by the FDA in the development of new medications, this study was reviewed by the FDA and an independent review board. It is only with your participation that new drugs will be available for future generations, improving quality of care and quality of life.